LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

UNH

321.58

+1.9%↑

ABT

135.18

-0.3%↓

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

UNH

321.58

+1.9%↑

ABT

135.18

-0.3%↓

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

UNH

321.58

+1.9%↑

ABT

135.18

-0.3%↓

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

UNH

321.58

+1.9%↑

ABT

135.18

-0.3%↓

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

ABBV

184.82

-0.47%↓

UNH

321.58

+1.9%↑

ABT

135.18

-0.3%↓

Search

Novo Nordisk A-S

Închisă

SectorSănătate

68.12 1.76

Rezumat

Modificarea prețului

24h

Curent

Minim

66.99

Maxim

69.85

Indicatori cheie

By Trading Economics

Venit

804M

29B

Vânzări

-7.6B

78B

P/E

Medie Sector

18.986

56.602

EPS

6.53

Randament dividend

2.41

Marjă de profit

37.182

Angajați

77,406

EBITDA

5.9B

46B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+37.54% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.41%

2.45%

Statistici piață

By TradingEconomics

Capitalizare de piață

26B

292B

Deschiderea anterioară

66.36

Închiderea anterioară

68.12

Sentimentul știrilor

By Acuity

27%

73%

69 / 382 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Novo Nordisk A-S Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 mai 2025, 11:36 UTC

Top știri

Novo Nordisk CEO to Step Down Amid Market Challenges

12 mai 2025, 09:36 UTC

Principalele dinamici ale pieței

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

7 mai 2025, 11:29 UTC

Top știri
Câștiguri
Principalele dinamici ale pieței

Novo Nordisk Investors Breathe Sigh of Relief Despite Guidance Hit From Copycat Drugs -- 2nd Update

7 mai 2025, 07:05 UTC

Câștiguri

Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales -- Update

7 mai 2025, 06:19 UTC

Câștiguri

Novo Nordisk Cuts Guidance as Copycat Versions of Ozempic Hit Sales

20 mai 2025, 14:08 UTC

Câștiguri

Novo Nordisk Woes Weigh on Denmark's Economy. Here's How. -- Barrons.com

20 mai 2025, 07:43 UTC

Market Talk

Novo Nordisk Guidance at Risk After CEO News -- Market Talk

16 mai 2025, 18:35 UTC

Top știri

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 3rd Update

16 mai 2025, 17:34 UTC

Top știri

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- 2nd Update

16 mai 2025, 13:42 UTC

Acțiuni populare

Stocks to Watch Friday: Charter, Novo Nordisk, Applied Materials -- WSJ

16 mai 2025, 13:27 UTC

Market Talk

Novo Nordisk CEO Departure Comes as a Surprise -- Market Talk

16 mai 2025, 13:15 UTC

Top știri

Ozempic Drugmaker's CEO Pushed Out Amid Weight-Loss Market Challenges -- Update

16 mai 2025, 12:17 UTC

Câștiguri

Novo Nordisk Chairman: No Link Between CEO Change and Other Recent Exec Departures

12 mai 2025, 22:14 UTC

Top știri

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 mai 2025, 18:45 UTC

Top știri

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- Update

12 mai 2025, 12:07 UTC

Market Talk

Trump's Drug Price Cap Plan Is 'Alarming' for Pharma Sector -- Market Talk

12 mai 2025, 07:20 UTC

Market Talk

Pharma Shares Face Risks From Trump's Pricing Plans -- Market Talk

7 mai 2025, 15:13 UTC

Câștiguri

These Stocks Are Moving the Most Today: Super Micro, AMD, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More -- Barrons.com

7 mai 2025, 13:56 UTC

Câștiguri

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

7 mai 2025, 13:45 UTC

Câștiguri

These Stocks Are Moving the Most Today: Super Micro, AMD, Marvell, Disney, Uber, Nordisk, Sarepta, EA, Upstart, and More -- Barrons.com

7 mai 2025, 11:25 UTC

Câștiguri

These Stocks Are Moving the Most Today: Super Micro, AMD, Disney, Uber, Novo Nordisk, Sarepta, EA, Tesla, and More -- Barrons.com

7 mai 2025, 11:18 UTC

Câștiguri

Novo Nordisk Stock Jumps After Earnings. It Cuts Guidance as Weight-Loss Drug Sales Slow. -- Barrons.com

7 mai 2025, 09:55 UTC

Câștiguri

These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Disney, and More -- Barrons.com

7 mai 2025, 09:36 UTC

Câștiguri

These Stocks Are Moving the Most Today: Super Micro, AMD, Novo Nordisk, Sarepta, EA, Rivian, Tesla, and More -- Barrons.com

7 mai 2025, 09:04 UTC

Câștiguri
Acțiuni populare

Stocks to Watch Wednesday: Disney, Uber, Super Micro -- WSJ

7 mai 2025, 08:10 UTC

Market Talk

Novo Nordisk Cuts Guidance Slightly More Than Expected -- Market Talk

7 mai 2025, 08:08 UTC

Market Talk

Novo Nordisk's Downgraded Guidance Assumes Large Wegovy Uplift in 2H -- Market Talk

7 mai 2025, 07:11 UTC

Market Talk
Câștiguri

Novo Nordisk Shares Seen Under Pressure After Downgrade -- Market Talk

7 mai 2025, 05:39 UTC

Câștiguri

Novo Nordisk: Sales Outlook Assumes Reduction in Patients on Compounded GLP-1 Treatments During 2H25

7 mai 2025, 05:38 UTC

Câștiguri

Novo Nordisk 1Q Wegovy Drug Sales Rose 83% To DKK17.36B, Consensus Saw DKK18.5B

Comparație

Modificare preț

Novo Nordisk A-S Așteptări

Obiectiv de preț

By TipRanks

37.54% sus

Prognoză pe 12 luni

Medie 92.18 USD  37.54%

Maxim 137.101 USD

Minim 61 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovo Nordisk A-S - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

9 ratings

3

Cumpărare

5

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

62.63 / 69.23Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

69 / 382 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Novo Nordisk A-S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.